NEW YORK (GenomeWeb News) - Illumina said yesterday that it has filed a resale registration statement with the US Securities and Exchange Commission connected to the sale of $400 million worth of .625 percent convertible senior notes due 2014.
 
The notes were originally sold in February to institutional investors, and Illumina said at the time it planned to use $200 million of the proceeds to buy shares of its own stock in a private deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.